MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....conduct and/or complete prescribed studies on production batches of a drug after approval.....program because they can affect the ability of the product to deliver reproducible doses..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)

stability guidance -draft
...Information to support the stability of the drug product during the toxicologic studies and the.....this guidance to mean a batch of drug substance or drug product manufactured at the scale typically encountered.....include results from microbial challenge studies performed on the drug product at..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=67)

Office of Drug Safety Annual Report 2001
...This includes, for example, product labeling, development of drug distribution systems.....Other topics may include the need for postmarketing safety studies, patient registries, or.....Clinical Trials Course "Regulatory Perspectives on Metabolism-Based Drug-Drug Interactions..
http://www.fda.gov/cder/Offices/ODS/AnnRep2001/annualreport2001.htm (score=64)

Document
...Manufacturing, and Controls Reviewers of Human Gene Therapy In-vestigational New Drug.....Use of Field Studies to Demonstrate the Effectiveness of a New Animal Steven Vaughn and.....Assessment of the Effects of Antimicrobial Drug Residues From Food Haydee Fernandez..
http://www.fda.gov/OHRMS/DOCKETS/98fr/03-8262.pdf (score=64)

Document
...To describe the use of bridging studies, assess an application for registration for: 1.3.....Pharmaceutical Industries Associations, approved or pending drug product.. of ethnic.....Food and Drug Administration, the goals of harmonization is to identify.. clinical studies..
http://www.fda.gov/cder/guidance/2293fnl.pdf (score=64)

ICH: Guidance on Ethnic Factors in the Acceptability of Foreign Clinical Data
...To describe the use of bridging studies, assess an application for registration for: 1.3.....Pharmaceutical Industries Associations, approved or pending drug product.. of ethnic.....Food and Drug Administration, the goals of harmonization is to identify.. clinical studies..
http://www.fda.gov/cber/gdlns/ichethnic.pdf (score=64)

Federal Register - Annual Guidance Agenda
...Manufacturing, and Controls Reviewers of Human Gene Therapy In-vestigational New Drug.....Use of Field Studies to Demonstrate the Effectiveness of a New Animal Steven Vaughn and.....Assessment of the Effects of Antimicrobial Drug Residues From Food Haydee Fernandez..
http://www.fda.gov/cber/gdlns/fr-annguiagenda.pdf (score=64)

6003dft.doc
...changes and that no adverse impact on the quality, safety, or efficacy of the drug product.....therefore, real-time concurrent stability studies on the product potentially affected by.....contractual arrangement to produce the intermediates, drug substance, or drug product on..
http://www.fda.gov/cder/guidance/6003dft.pdf (score=61)

Draft Guidance: ICH Q5E: Comparability of Biotechnological/Biological...
...The tests and analytical procedures chosen to define drug substance or drug product specifications alone are.....Generally, therefore, real-time concurrent stability studies on the product potentially.....Therefore, it might be appropriate to collect data on the drug product to support the..
http://www.fda.gov/cber/gdlns/ichcompbio.htm (score=60)

International Conference on Harmonisation; Draft Guidance on Q5E...
...changes and that no adverse impact on the quality, safety, or efficacy of the drug product.....therefore, real-time concurrent stability studies on the product potentially affected by.....contractual arrangement to produce the intermediates, drug substance, or drug product on..
http://www.fda.gov/cber/gdlns/ichcompbio.pdf (score=57)

Q1B Photostability Testing of New Drug Substances and Products
...The extent of drug product testing should be established by assessing whether or not acceptable.....These studies, which may be undertaken in the development phase normally on the drug.....Testing should progress until the results demonstrate that the drug product is adequately..
http://www.fda.gov/cder/guidance/1318.htm (score=55)

IND content and format for Phase 1 studies
...As clinical development of a drug product proceeds,sponsors should discuss the manufacturing.....being proposed for use in a clinical study to the drug product used in..the animal toxicology studies that support the safety of the.....procedures for drug products used in Phase 1 clinical studies. Additional information should ordinarily be submitted for review..
http://www.fda.gov/cder/guidance/phase1.pdf (score=54)

Content and Format of INDs for Phase 1 Studies of Drugs, Inclu
...proposed for use in a clinical study to the drug product used in the animal..toxicology studies.....Food and Drug Administration, Center for Drug Evaluation and Research,"IND Process and.....manufacturing differences between the drug product proposed for..clinical use and the drug..
http://www.fda.gov/cder/guidance/clin2.pdf (score=54)

WAIS Document Retrieval
...FDA will also provide its best judgment, at that time, of the pediatric studies that will be required for the drug product and.....Final specifications for the drug substance and drug product are not expected until the end of the investigational.....If the drug is a radioactive drug, sufficient data from animal or human studies to allow a reasonable calculation of radiation..
http://www.fda.gov/cber/ind/21cfr312.htm (score=52)

...No extensive dose range and dose adjustment studies with this drug product in normal and special populations have.....This drug product has been used to measure deoxyglucose metabolism in a variety of tissues, e.g.....The initial search criteria included studies published and written in English from January..
http://www.fda.gov/ohrms/dockets/dockets/98d0266/ref0001l.doc (score=51)

...Systemic exposure patterns reflect both release of the drug substance from the drug product and a series of possible.....As part of INDs and NDAs for orally administered drug products, BA studies focus on determining the process.....General Recommendations For product quality BA and BE studies, we recommend that where the focus is on release of..
http://www.fda.gov/cder/guidance/5356fnl.doc (score=51)

Guidance for Industry Botanical Drug Products
...These regulations require documentation of the drug substance, drug product, placebo, labeling, and an.....E provide information on the design of initial clinical trials for nonmarketed botanical drug products and for expanded.....one in which the components or ingredients and composition of the drug substance and drug product are kept..
http://www.fda.gov/cder/guidance/4592fnl.htm (score=49)

Document
...foreign marketing developments with treatment use under a treatment pro-the drug during.....In general, protocols for group to be used, if any, and a descrip-Phase 1 studies may be.....drug product and those which with additional information pertinent ..may not appear but which..
http://www.fda.gov/cber/ind/21cfr312.pdf (score=48)

Recommendations for Complying With the Pediatric Rule (21 CFR 314.55(a) and...
...In some cases, pediatric studies of a drug or biological product for life-threatening diseases may begin as early as phase.....You can get specific information about the types of pediatric studies that should be conducted for your drug product from the.....Where possible, an estimate of patient exposure to the drug product, with special reference to..
http://www.fda.gov/cder/guidance/3578dft.htm (score=46)

...In some cases, pediatric studies of a drug or biological product for life-threatening diseases may begin as early as phase.....You can get specific information about the types of pediatric studies that should be conducted for your drug product from the.....Where possible, an estimate of patient exposure to the drug product, with special reference to..
http://www.fda.gov/cder/guidance/3578dft.doc (score=46)

Las Vegas Injury Lawyer